Description

6-Bromo-7-Fluoro-2,3-Dihydrobenzo[B][1,4]Dioxine is a high-purity, advanced pharmaceutical intermediate with a unique halogenated benzodioxine core structure. This compound is critical for the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring precise molecular modification. It is primarily utilized by research institutions and manufacturers in the pharmaceutical, agrochemical, and advanced materials sectors for developing new drug candidates and specialty chemicals.

Application

• Pharmaceutical Intermediate: A key building block for the synthesis of complex drug molecules, especially in central nervous system (CNS) and oncology research.
• Agrochemical Synthesis: Used in the development of new-generation herbicides and pesticides with enhanced efficacy and selectivity.
• Material Science Research: Serves as a precursor for creating novel organic electronic materials and liquid crystals.
• Chemical Biology Probes: Employed in the design of molecular probes for studying enzyme mechanisms and biological pathways.
• Custom Synthesis & Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for scale-up and commercial production.

Basic Information

Product Name	6-Bromo-7-Fluoro-2,3-Dihydrobenzo[B][1,4]Dioxine
CAS No.	69464-29-5
Molecular Formula	C8H6BrFO2
Molecular Weight	233.04 g/mol
Synonyms	6-Bromo-7-fluoro-2,3-dihydro-1,4-benzodioxine; 7-Fluoro-6-bromo-2,3-dihydro-1,4-benzodioxine; 2,3-Dihydro-6-bromo-7-fluoro-1,4-benzodioxine; 6-Bromo-7-fluoro-2,3-dihydrobenzo-1,4-dioxine; 69464-29-5; Benzo[1,4]dioxine, 6-bromo-7-fluoro-2,3-dihydro-
EINECS	Contact for details

Quality Control

Our 6-Bromo-7-Fluoro-2,3-Dihydrobenzo[B][1,4]Dioxine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, GC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specifications. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliable supply for critical research and development projects.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Keep away from strong oxidizing agents. For long-term storage, consider storing under an inert atmosphere to maintain optimal purity.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Melting Point	Contact for details
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.